Drugs that alter inhibitory targets offer therapeutic strategies for autism, schizophrenia
In a study published in Cell Reports in February 2017, Matt Rowan, Ph.D., a Post-doctoral researcher in the lab of Dr. Jason Christie, sought to understand the molecular mechanisms behind a type of short-term neuronal plasticity …